Earnings Call · Q4 FY2021·2022-03-29

Q4 21EPS +4.76%·Rev n/aQ3 21EPS +42.86%·Rev n/aQ2 21EPS +13.04%·Rev n/aQ1 21EPS +25.00%·Rev n/a⚠ consensus missing

BioCardia, Inc. BCDA

Disclaimer*

Jules Abraham — Investor Relations or Communications

Peter Altman — President and Chief Executive Officer

David McClung — Chief Financial Officer

+3.4%1d on move date+2.2% vs SPY3d+1.0%5d+5.9%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BCDA calls or request research access.

More BCDA calls Browse calls Request research access